A detailed history of Silverarc Capital Management, LLC transactions in Biodesix Inc stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 3,561,094 shares of BDSX stock, worth $5.59 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
3,561,094
Previous 1,808,959 96.86%
Holding current value
$5.59 Million
Previous $2.77 Million 129.06%
% of portfolio
1.58%
Previous 0.78%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.53 - $1.96 $2.68 Million - $3.43 Million
1,752,135 Added 96.86%
3,561,094 $6.34 Million
Q2 2024

Aug 14, 2024

BUY
$1.21 - $1.71 $2.19 Million - $3.09 Million
1,808,959 New
1,808,959 $2.77 Million

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $62.8M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.